RE:RE:RE:Other regional deals could follow quicklySir_Holler.<br /> <br /> The Hepalink deal closure gives access of rvx-208 to 13.4% of the worlds GDP as estimated by the IMF for 2014. This is a $10.4 trillion (USA$) economy so I think there is room for this important drug.<br /> <br /> The approval for phase lll BETonMACE in the EU gives access to 23.9% of the worlds GDP based on IMF 2014 estimates (a $18.5 trillion economy).<br /> <br /> So if, and it is still a possibility, the BoM phlll is approved for DM,CVD,low HDL in the USA that will give access to another 22.5% of the worlds economy or and additional $17.4 trillion GDP (USA$) economy.<br /> <br /> I'm very happy with the EU and the Territories (China, Hong Kong, Taiwan, Macau). These countries are more nimble than the USA and have a sense of urgency.<br /> <br /> The sense of urgency is also accelerated by the business model with Hepalink.<br /> <br /> The FDA will fall into line as results come in from more progressive countries, and, if not, please keep in mind that the USA is only roughly 4% of the worlds population.<br /> <br /> Of course health care costs in the USA are some of the highest costs in the world and yet access to health care lags far behind most developed countries in the world. The implication is that the profits will be huge when rvx-208 finally gets into the USA.<br /> <br /> So I fully agree with you.<br /> <br /> Cheers...I'm off to the lake.<br /> Toinv :)